Lupifos Powder contains Fosfomycin 3gm, a broad-spectrum antibiotic used for the treatment of various bacterial infections. Fosfomycin acts by inhibiting bacterial cell wall synthesis, leading to cell death and effective eradication of susceptible pathogens. It is primarily indicated for uncomplicated urinary tract infections caused by Escherichia coli and Enterococcus faecalis, including acute cystitis in women. The powder formulation allows for convenient oral administration after reconstitution with water, ensuring rapid absorption and high urinary concentrations. Lupifos Powder is particularly valuable in cases where resistance to other antibiotics is a concern, offering an alternative therapeutic option. The drug demonstrates a favorable safety profile with minimal adverse effects, although hypersensitivity reactions may occur in rare instances. It is contraindicated in patients with known hypersensitivity to fosfomycin or any of its components. Dosage should be adjusted according to the severity of infection and patient-specific factors such as renal function. Caution is advised when used concomitantly with other nephrotoxic agents. As with all antibiotics, it is essential to complete the prescribed course to prevent the development of resistance. Lupifos Powder should be stored in a cool, dry place and kept out of reach of children.